The melatonergic agonist and clinically active antidepressant, agomelatine, is a neutral antagonist at 5-HT2C receptors
出版年份 2010 全文链接
标题
The melatonergic agonist and clinically active antidepressant, agomelatine, is a neutral antagonist at 5-HT2C receptors
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
Volume 14, Issue 06, Pages 768-783
出版商
Oxford University Press (OUP)
发表日期
2010-10-15
DOI
10.1017/s1461145710001045
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Improved donor/acceptor BRET couples for monitoring β-arrestin recruitment to G protein-coupled receptors
- (2009) Maud Kamal et al. Biotechnology Journal
- Improving antidepressant drugs: update on recently patented compounds
- (2009) Isabel Rozas EXPERT OPINION ON THERAPEUTIC PATENTS
- Behavioural and neuroplastic effects of the new-generation antidepressant agomelatine compared to fluoxetine in glucocorticoid receptor-impaired mice
- (2009) Eleni Païzanis et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Agomelatine Prevents Relapse in Patients With Major Depressive Disorder Without Evidence of a Discontinuation Syndrome
- (2009) Guy M. Goodwin et al. JOURNAL OF CLINICAL PSYCHIATRY
- Mechanisms Contributing to the Phase-Dependent Regulation of Neurogenesis by the Novel Antidepressant, Agomelatine, in the Adult Rat Hippocampus
- (2009) Amélie Soumier et al. NEUROPSYCHOPHARMACOLOGY
- Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleep–wake cycle architecture
- (2009) Amandine Descamps et al. PSYCHOPHARMACOLOGY
- Beyond the monoaminergic hypothesis: Agomelatine, a new antidepressant with an innovative mechanism of action
- (2009) Siegfried Kasper et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Pharmacology of 5HT2C receptor-mediated ERK1/2 phosphorylation: Agonist-specific activation pathways and the impact of RNA editing
- (2008) Tim D. Werry et al. BIOCHEMICAL PHARMACOLOGY
- Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells
- (2008) Didier Cussac et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Circadian rhythm disturbances in depression
- (2008) Anne Germain et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Activation of 5-HT2A/CReceptors Counteracts 5-HT1ARegulation ofN-Methyl-D-aspartate Receptor Channels in Pyramidal Neurons of Prefrontal Cortex
- (2008) Eunice Y. Yuen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Efficacy of Agomelatine in Generalized Anxiety Disorder
- (2008) Dan J. Stein et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Serotonin 5-HT2B Receptors Are Required for 3,4-Methylenedioxymethamphetamine-Induced Hyperlocomotion and 5-HT Release In Vivo and In Vitro
- (2008) S. Doly et al. JOURNAL OF NEUROSCIENCE
- Better sexual acceptability of agomelatine (25 and 50 mg) compared with paroxetine (20 mg) in healthy male volunteers. An 8-week, placebo-controlled study using the PRSEXDQ-SALSEX scale
- (2008) AL Montejo et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Physical Interaction of Calmodulin with the 5-Hydroxytryptamine2C Receptor C-Terminus Is Essential for G Protein-independent, Arrestin-dependent Receptor Signaling
- (2008) Marilyne Labasque et al. MOLECULAR BIOLOGY OF THE CELL
- Pharmacological characterization of mitogen-activated protein kinase activation by recombinant human 5-HT2C, 5-HT2A, and 5-HT2B receptors
- (2008) Christopher S. Knauer et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors
- (2008) V.J. Aloyo et al. PHARMACOLOGY & THERAPEUTICS
- Agonist-directed signaling of the serotonin 2A receptor depends on -arrestin-2 interactions in vivo
- (2008) C. L. Schmid et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models
- (2008) Anne Dekeyne et al. PSYCHOPHARMACOLOGY
- Fluoxetine-mediated 5-HT2B receptor stimulation in astrocytes causes EGF receptor transactivation and ERK phosphorylation
- (2008) Baoman Li et al. PSYCHOPHARMACOLOGY
- Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions
- (2008) M MILLAN et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now